Get the Stockscreener App
16.63
4.59%
0.73
After Hours:
16.63
Kestra Medical Technologies Ltd stock is traded at $16.63, with a volume of 401.08K.
It is up +4.59% in the last 24 hours and up +10.65% over the past month.
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
See More
Previous Close:
$15.90
Open:
$16.06
24h Volume:
401.08K
Relative Volume:
1.41
Market Cap:
$853.93M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+7.78%
1M Performance:
+10.65%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$15.88
$16.71
1-Week Range:
$13.25
$17.07
52-Week Range:
$13.25
$26.15
Kestra Medical Technologies Ltd Stock (KMTS) Company Profile
Name
Kestra Medical Technologies Ltd
Sector
Industry
Phone
(425) 279-8002
Address
3933 LAKE WASHINGTON BLVD NE, KIRKLAND
Compare KMTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KMTS
Kestra Medical Technologies Ltd
|
16.63 | 792.31M | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
516.12 | 185.10B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
175.33 | 50.76B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.16 | 43.19B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
261.07 | 37.26B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
210.08 | 16.13B | 2.90B | 467.20M | 306.90M | 6.37 |
Kestra Medical Technologies Ltd Stock (KMTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Initiated | BofA Securities | Buy |
| Mar-31-25 | Initiated | Goldman | Neutral |
| Mar-31-25 | Initiated | Piper Sandler | Overweight |
| Mar-31-25 | Initiated | Stifel | Buy |
| Mar-31-25 | Initiated | Wells Fargo | Overweight |
| Mar-31-25 | Initiated | Wolfe Research | Outperform |
View All
Kestra Medical Technologies Ltd Stock (KMTS) Latest News
What drives Kestra Medical Technologies Ltd. stock priceDynamic investment growth - Autocar Professional
Wells Fargo & Company Cuts Kestra Medical Technologies (NASDAQ:KMTS) Price Target to $27.00 - MarketBeat
Kestra Medical Technologies Ltd. Stock Analysis and ForecastUnprecedented growth rates - Autocar Professional
Is Kestra Medical Technologies Ltd. a good long term investmentStrong return on assets - jammulinksnews.com
What analysts say about Kestra Medical Technologies Ltd. stockMassive profits - PrintWeekIndia
Kestra Medical Technologies (NASDAQ:KMTS) Hits New 52-Week LowTime to Sell? - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Up 7.8%Should You Buy? - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Posts Quarterly Earnings Results, Misses Expectations By $1.55 EPS - MarketBeat
Kestra Medical Technologies Wins 2025 Top Workplaces Industry Award, A National Recognition - GlobeNewswire
Kestra Medical Technologies Clinches Elite Healthcare Workplace Award: What Sets This Medical Device Leader Apart - Stock Titan
Kestra Medical Technologies Reports Strong Revenue Growth - The Globe and Mail
Kestra Stock Slips as Heavy Q4 Loss Overshadows Big Revenue Gains - Yahoo Finance
Kestra Medical Technologies stock rating reiterated by Piper Sandler - Investing.com South Africa
Stifel reiterates Buy rating on Kestra Medical Technologies stock after strong earnings - Investing.com Australia
Kestra Medical Technologies Ltd.: Balanced Hold Rating Amid Revenue Growth and EBITDA Challenges - TipRanks
Stifel reiterates Buy rating on Kestra Medical Technologies stock after strong earnings By Investing.com - Investing.com South Africa
Kestra Medical Technologies’ revenue jumps 71% in Q4FY25 - Medical Buyer
Kestra Medical Technologies falls on Q4 loss despite revenue growth - Investing.com
Why Kestra Medical Technologies Ltd. stock attracts strong analyst attentionFree Stock Selection with 300% Return - Newser
Earnings call transcript: Kestra Medical Technologies sees strong Q4 growth in 2025 - Investing.com Australia
Kestra Medical Technologies Q4 2025 Earnings Call Transcript - MarketBeat
Kestra Medical Technologies falls on Q4 loss despite revenue growth By Investing.com - Investing.com South Africa
Kestra Medical Technologies Ltd reports results for the quarter ended April 30Earnings Summary - TradingView
Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2025 Financial Results - The Globe and Mail
Kestra Medical Technologies Reports Strong Q4 and FY25 Financial Results, Projects Continued Growth for FY26 - Nasdaq
Kestra Medical sees FY26 revenue $85M, consensus $82.91M - TipRanks
Earnings Flash (KMTS) Kestra Medical Technologies, Ltd. Reports Q4 Revenue $17.2M - MarketScreener
What makes Kestra Medical Technologies Ltd. stock price move sharplyLow Risk Trading Ideas - Newser
How Kestra Medical Technologies Ltd. stock performs during market volatilityMarket Ready Callouts - Newser
Caas Capital Management LP Acquires New Stake in Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) - MarketBeat
Kestra Medical Technologies Ltd Stock (KMTS) Financials Data
There is no financial data for Kestra Medical Technologies Ltd (KMTS). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):